Implementing the Medicare $2 drug list model would have reduced out-of-pocket spending by 63% for Part D beneficiaries in 2021. The model caps cost-sharing at $2 for a 30-day supply of 101 generic ...

Analysts and investors had long understood that Ozempic and Wegovy would appear on the list of drugs with negotiated Medicare ...

About 5.3 million people with Medicare Part D coverage used the 15 drugs on the second-round list to treat various conditions, such as asthma, cancer and Type 2 diabetes, between Nov. 1 ...

The Department of Health and Human Services (HHS) has released a new list of Medicare Part B drugs that will have lower coinsurance rates from April 1 to June 30 if drugmakers raise their prices ...

Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

Insurance, if it's covered, can lower the cost, but it is still too pricey for many. Medicare’s list includes drugs that cost taxpayers billions The list includes 15 drugs the White House plans ...

Novartis has responded to the inclusion of its heart failure blockbuster Entresto on the list of the first 10 drugs that will be subject to Medicare pricing negotiations, claiming that the move ...